Neurofibromatoses Type II Pipeline Assessment Review H1 2015 Research Report Available at RnRMarketResearch.com
The report "Neurofibromatoses Type II - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Neurofibromatoses Type II, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Progressive Supranuclear Palsy and special features on late-stage and discontinued projects.
View full press release